Related Experiment Video
Updated: Sep 5, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Nuclear Coregulatory Complexes in Tregs as Targets to Promote Anticancer Immune Responses
Lanette M Christensen1, Wayne W Hancock1,2
1Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Abstract:
T-regulatory (Treg) cells display considerable heterogeneity in their responses to various cancers. The functional differences among this cell type are heavily influenced by multiprotein nuclear complexes that control their gene expression. Many such complexes act mechanistically by altering epigenetic profiles of genes important to Treg function, including the forkhead P3 (Foxp3) transcription factor. Complexes that form with certain members of the histone/protein deacetylase (HDAC) class of enzymes, like HDACs 1, 2, and 3, along with histone methyltransferase complexes, are important in the induction and stabilization of Foxp3 and Treg identity. The functional behavior of both circulating and intratumoral Tregs greatly impacts the antitumor immune response and can be predictive of patient outcome. Thus, targeting these regulatory complexes within Tregs may have therapeutic potential, especially in personalized immunotherapies.
Insights
Regulatory complexes influence T-regulatory (Treg) cell function in cancer. Targeting these epigenetic regulators, including histone deacetylases (HDACs), may offer new cancer immunotherapy strategies.
Area of Science:
- Immunology
- Epigenetics
- Cancer Biology
Background:
- T-regulatory (Treg) cells exhibit diverse responses in cancer, impacting antitumor immunity.
- Treg cell function is modulated by multiprotein nuclear complexes controlling gene expression.
- Epigenetic modifications, particularly involving histone deacetylases (HDACs), are crucial for Treg stability and identity.
Purpose of the Study:
- To investigate the role of multiprotein nuclear complexes in Treg heterogeneity in cancer.
- To explore the impact of epigenetic regulators, such as HDACs, on Treg function and cancer response.
- To assess the therapeutic potential of targeting Treg-associated regulatory complexes in cancer immunotherapy.
Main Methods:
- Analysis of Treg cell populations in cancer patients.
- Investigation of epigenetic modifications within Treg cells.
- Characterization of multiprotein complexes involving HDACs and histone methyltransferases.
- Assessment of Treg functional impact on antitumor immune responses.
Main Results:
- Treg cell heterogeneity significantly influences cancer progression and patient outcomes.
- Epigenetic regulators, including HDACs 1, 2, and 3, are critical for maintaining Foxp3 expression and Treg identity.
- Specific multiprotein complexes directly impact Treg gene expression and epigenetic profiles.
Conclusions:
- Multiprotein complexes, particularly those involving HDACs, are key determinants of Treg function in cancer.
- Targeting these epigenetic regulatory complexes in Tregs presents a promising avenue for developing personalized cancer immunotherapies.
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

